Processa Pharmaceuticals, Inc. (PCSA)
NASDAQ: PCSA · Real-Time Price · USD
0.680
-0.047 (-6.46%)
Jan 22, 2025, 9:43 AM EST - Market open
Processa Pharmaceuticals Employees
Processa Pharmaceuticals had 13 employees as of December 31, 2023. The number of employees decreased by 2 or -13.33% compared to the previous year.
Employees
13
Change (1Y)
-2
Growth (1Y)
-13.33%
Revenue / Employee
n/a
Profits / Employee
-$886,642
Market Cap
2.22M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
PCSA News
- 3 months ago - Processa Pharmaceuticals Announces First Patient Dosed in Phase 2 Clinical Trial of NGC-Cap in Metastatic Breast Cancer - GlobeNewsWire
- 5 months ago - Processa Pharmaceuticals to Participate in Investor and Industry Conferences During September - GlobeNewsWire
- 8 months ago - Processa Pharmaceuticals Announces Positive Efficacy Results from Preliminary Evaluation of Phase 1b Dose-escalating Trial with NGC-Cap in Gastrointestinal Cancer - GlobeNewsWire
- 9 months ago - Processa Pharmaceuticals to Participate in the EF Hutton Annual Global Conference - GlobeNewsWire
- 9 months ago - Processa Pharmaceuticals Names Dr. Steven Cha Senior Vice President of Clinical Research - GlobeNewsWire
- 10 months ago - Processa Pharmaceuticals to Present at the MedInvest Biotech and Pharma Investor Conference - GlobeNewsWire
- 10 months ago - Processa Pharmaceuticals to Present Data at the American Association for Cancer Research Annual Meeting - GlobeNewsWire
- 1 year ago - Processa Pharmaceuticals to Present at the 2024 BIO CEO & Investor Conference - GlobeNewsWire